A phase I trial of epirubicin, carboplatin and capecitabine in adult cancer patients
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Carboplatin; Epirubicin
- Indications Solid tumours
- Focus Adverse reactions
- 26 Jan 2018 Biomarkers information updated
- 13 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Oct 2008 Planned number of patients changed from 41 to 46 as reported by ClinicalTrials.gov.